Showing 3201-3210 of 7638 results for "".
- Daavlin, HealthLens Partner to Increase Phototherapy Accesshttps://practicaldermatology.com/news/daavlin-healthlens-partner-to-increase-phototherapy-access/2460232/Daavlin, a leading U.S. manufacturer of phototherapy units, is teaming up with HealthLens to increase access to phototherapy via teledermatology. Appointment wait times for dermatology services have increased by 46 percent since 2009, according to a by Greater Access for Patient Partners (GAPP). T…
- CSF Kicks Off in Nashvillehttps://practicaldermatology.com/news/csf-kicks-off-in-nashville/2460229/Cosmetic Surgery Forum (CSF), now in its 11th year, has kicked off in Nashville. It’s the meeting’s first time in the Music City, which allows for live injection sessions—a popular meeting highlight. The program covers everything from cannabidiol (CBD) in skincare and platelet-rich plasma (PRP) for…
- Cutera Rolls Out Heroes Among Us Programhttps://practicaldermatology.com/news/cutera-rolls-out-heroes-among-us-program/2460228/Cutera is launching its new “Heroes Among Us” program to showcase patients who’ve been positively affected by Cutera technologies. The new program was launched at the Cutera University Clinical Forum (CUCF) in Scottsdale, AZ. From bariatric patients whose lives have been restored with the help o…
- Norfolk Dermatologist Recognized for Increasing Accessibility for Patientshttps://practicaldermatology.com/news/norfolk-dermatologist-recognized-for-increasing-accessibility-for-patients/2460227/Dermatologist Abby Van Voorhees, MD, FAAD, is an American Academy of Dermatology Patient Care Hero for her leadership at the Rapid Access Clinic at the Eastern Virginia Medical School Dermatology Practice in Norfolk, Va. The Eastern Virginia Medical School Dermatology practice allows anyone with a…
- CBD Brands Initiates AD studyhttps://practicaldermatology.com/news/cbd-brands-initiates-ad-study-1/2460226/In the wake of the US Food and Drug Administration’s (FDA) recent revised warning about the risks of CBD products, CBD Brands is initiating a study to investigate a novel cannabidiol lotion for the treatment of atopic dermatitis (AD). The study aims to provide a preliminary assessment of the safet…
- NavaDerm Partners Adds Dan Wechsler as Executive Chairmanhttps://practicaldermatology.com/news/navaderm-partners-adds-dan-wechsler-as-executive-chairman/2460225/Dan Wechsler is the new Executive Chairman of NavaDerm Partners, a Northeast-focused dermatology services company and portfolio company of BelHealth Investment Partners, a New York-based healthcare private equity firm. Wechsler served as President and CEO of Smile Brands, a privately held dental s…
- Revance Files BLA for DAXIhttps://practicaldermatology.com/news/revance-files-bla-for-daxi/2460224/Revance Therapeutics, Inc. has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for DaxibotulinumtoxinA for Injection (DAXI) in the treatment of moderate to severe glabellar lines. Under the current Prescription Drug User Fee Agreement (PDUFA VI), the …
- Baring Private Equity Asia Agrees to Acquire Lumenishttps://practicaldermatology.com/news/baring-private-equity-asia-agrees-to-acquire-lumenis-1/2460222/Baring Private Equity Asia’s affiliated private equity funds are acquiring Lumenis. The transaction, which values Lumenis at an enterprise value of more than $1 billion, remains subject to the customary regulatory approval process. It is expected to be completed in early 2020. "Baring Private Equi…
- Celebrate National Botox Day on November 20, 2019https://practicaldermatology.com/news/celebrate-national-botox-day-on-november-20th-2019/2460218/Mark your calendars: November 20, 2019 will be the first-ever National Botox Cosmetic Day. Why Nov. 20? It is the busiest day on record for booking Botox cosmetic treatments in the US. And to commemorate it, Allergan is offering an exclusive deal for one day only where patients can “buy one, get …
- Allergan Pays Exicure $25M upfront in Collaboration Deal to Develop Hair Loss Treatmenthttps://practicaldermatology.com/news/allergan-pays-exicure-25m-upfront-in-collaboration-deal-to-develop-hair-loss-treatment/2460216/Allergan Pharmaceuticals International Limited has entered into a global collaboration agreement with Exicure to discover and develop novel treatments for hair loss disorders based on Exicure’s proprietary SNA technology. Allergan will receive exclusive access and options to license SNA-based ther…